Condition:   Rheumatoid Arthritis
Interventions:   Drug: rituximab [MabThera/Rituxan];   Drug: rituximab [MabThera/Rituxan];   Drug: rituximab [MabThera/Rituxan]
Sponsor:   Hoffmann-La Roche
Active, not recruiting - verified July 2011